• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Avanir

Pharma

Eisai, GSK, Daiichi Sankyo—Fierce Pharma Asia

Eisia's lecanemab phase 3 had one patient death. China suspends GSK from volume-based procurement. Daiichi increases its Enhertu sales projection.
Angus Liu Nov 4, 2022 9:00am

Astellas, Takeda, Lilly-Innovent and more—FiercePharmaAsia

Jan 17, 2020 8:40am

Otsuka's Avanir unit plots 140 layoffs after Nuedexta settlement

Jan 10, 2020 11:35am

Otsuka, China's bidding, Aurobindo and more—FiercePharmaAsia

Sep 27, 2019 10:10am

Avanir agrees to pay $116M over Nuedexta kickbacks probe

Sep 26, 2019 3:55pm

Feds put Acadia's Nuplazid marketing under the microscope

Mar 11, 2019 11:12am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy